Share

December 2014; 1 (4) ArticleOpen Access

Occurrence of hemolytic anemia in patients with GBS treated with high-dose IVIg

Thy P. Nguyen, Suur Biliciler, Amer Wahed, Kazim Sheikh
First published December 11, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000050
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1477

Share

Article Information

vol. 1 no. 4 e50
DOI: 
https://doi.org/10.1212/NXI.0000000000000050
PubMed: 
25520957
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received June 27, 2014
  • Accepted in final form October 24, 2014
  • First Published December 11, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Thy P. Nguyen, MD,
    2. Suur Biliciler, MD,
    3. Amer Wahed, MD and
    4. Kazim Sheikh, MD
  1. Thy P. Nguyen, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Suur Biliciler, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Amer Wahed, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Kazim Sheikh, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (T.P.N., S.B., K.S.) and Pathology (A.W.), University of Texas Health Science Center at Houston, TX.
  1. Correspondence to Dr. Nguyen: thy.p.nguyen{at}uth.tmc.edu

Article usage

Article usage: December 2014 to October 2023

AbstractFullPdfSource
Dec 201432215960Highwire
Jan 201516436534Highwire
Jan 201506328pmc
Feb 2015734922Highwire
Feb 201502516pmc
Mar 20156914415Highwire
Mar 201503415pmc
Apr 201571486Highwire
Apr 201502613pmc
May 201545326Highwire
May 20150268pmc
Jun 201528322Highwire
Jun 20150219pmc
Jul 201535308Highwire
Jul 201502412pmc
Aug 201558375Highwire
Aug 201502012pmc
Sep 2015233013Highwire
Sep 20150199pmc
Oct 201511276Highwire
Oct 20150203pmc
Nov 201532202Highwire
Nov 20150177pmc
Dec 201517594Highwire
Dec 20150293pmc
Jan 201631186Highwire
Jan 20160397pmc
Feb 2016213613Highwire
Feb 20160334pmc
Mar 2016302912Highwire
Mar 20160305pmc
Apr 201632274Highwire
Apr 20160368pmc
May 201634332Highwire
May 20160245pmc
Jun 201628244Highwire
Jun 20160319pmc
Jul 201614203Highwire
Jul 20160305pmc
Aug 201618202Highwire
Aug 20160241pmc
Sep 201613164Highwire
Sep 20160362pmc
Oct 2016181810Highwire
Oct 20160488pmc
Nov 2016233618Highwire
Nov 20160414pmc
Dec 201611245Highwire
Dec 20160173pmc
Jan 201716233Highwire
Jan 20170476pmc
Feb 201711181Highwire
Feb 20170468pmc
Mar 20179273Highwire
Mar 20170502pmc
Apr 201716244Highwire
Apr 201734246pmc
May 20179150Highwire
May 201712024pmc
Jun 20174252Highwire
Jun 201753637pmc
Jul 20174121Highwire
Jul 201713136pmc
Aug 201712115Highwire
Aug 201723033pmc
Sep 2017954Highwire
Sep 201722729pmc
Oct 2017695Highwire
Oct 201724042pmc
Nov 20171468Highwire
Nov 201764871pmc
Dec 20174145Highwire
Jan 20180122Highwire
Feb 2018092Highwire
Mar 20184294Highwire
Apr 20181475Highwire
Apr 201874144pmc
May 20180432Highwire
Jun 20181393Highwire
Jun 201833642pmc
Jul 20184446Highwire
Aug 20181266Highwire
Aug 201813946pmc
Sep 20180223Highwire
Oct 20180251Highwire
Nov 20183460Highwire
Dec 20180874Highwire
Jan 20191472Highwire
Feb 20194535Highwire
Mar 20193336Highwire
Apr 201933110Highwire
May 201921910Highwire
Jun 201922017Highwire
Jul 201911010Highwire
Aug 20193666Highwire
Sep 20193155Highwire
Oct 20195154Highwire
Nov 20190252Highwire
Dec 20191303Highwire
Jan 20203223Highwire
Feb 20203365Highwire
Mar 20200406Highwire
Apr 20201122Highwire
May 20200151Highwire
Jun 20201162Highwire
Jul 20200184Highwire
Aug 20200124Highwire
Sep 202052510Highwire
Oct 20201265Highwire
Nov 20200266Highwire
Dec 20203334Highwire
Jan 202143711Highwire
Feb 20211163Highwire
Mar 20216223Highwire
Apr 202132411Highwire
May 20215323Highwire
Jun 20215267Highwire
Jul 20214236Highwire
Aug 20214483Highwire
Sep 202101314Highwire
Oct 202153122Highwire
Nov 202113234Highwire
Dec 202133410Highwire
Jan 20222186Highwire
Feb 20221255Highwire
Mar 202224012Highwire
Apr 20221478Highwire
May 202213110Highwire
Jun 20225499Highwire
Jul 20224385Highwire
Aug 20225506Highwire
Sep 202245217Highwire
Oct 20223428Highwire
Nov 202287717Highwire
Dec 202215511Highwire
Jan 202345213Highwire
Feb 20232399Highwire
Mar 202322912Highwire
Apr 202342815Highwire
May 202362211Highwire
Jun 20232207Highwire
Jul 202311211Highwire
Aug 20232188Highwire
Sep 20232129Highwire
Oct 20231172Highwire

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles